Biotek-snakken — Januar 2022
-
Genmab/Citi: Kursmålet skæres næsten 14 pct. https://www.proinvestor.com/investornyt/763515/genmab-citi-kursmalet-skaeres-naesten-14-pct
-
Godt nok også mærkeligt, at Lilly/Zyme samarbejdet fejler sådan, og der blever ikke nævnt ét ord om det fra Zymeworks selv..
-
January 12, 2022 9:00 AM EST - January 12, 2022 9:40 AM EST : 40th Annual J.P. Morgan Healthcare Conference https://www.proinvestor.com/investornyt/763620/january-12-2022-900-am-est-january-12-2022-940-am-est-40th-annual-jp-morgan-healthcare-conference
-
Genmab: Topchef håber på snarlig afgørelse i vigtig voldgiftssag https://www.proinvestor.com/investornyt/764344/genmab-topchef-haber-pa-snarlig-afgorelse-i-vigtig-voldgiftssag
-
Genmab/Danske Bank: Anbefaling løftes til "køb" fra "hold" https://www.proinvestor.com/investornyt/764848/genmab-danske-bank-anbefaling-loftes-til-kob-fra-hold
-
3 Top Biotech Stocks to Buy Right Now https://www.proinvestor.com/investornyt/765621/3-top-biotech-stocks-to-buy-right-now
-
5 Top Biotech Stocks To Watch In January 2022 https://www.proinvestor.com/investornyt/766013/5-top-biotech-stocks-to-watch-in-january-2022
-
STENOCARE announces positive outcome of feasibility study https://www.proinvestor.com/index.php?p=debat_1&postid=100218
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind